Pallis M - Search Results

1

P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.

Pallis M, Turzanski J, Higashi Y, Russell N. Pallis M, et al. Leuk Lymphoma. 2002 Jun;43(6):1221-8. doi: 10.1080/10428190290026277. Leuk Lymphoma. 2002. PMID: 12152989 Review.

2

Resistance to spontaneous apoptosis in acute myeloid leukaemia blasts is associated with p-glycoprotein expression and function, but not with the presence of FLT3 internal tandem duplications.

Pallis M, Turzanski J, Grundy M, Seedhouse C, Russell N. Pallis M, et al. Br J Haematol. 2003 Mar;120(6):1009-16. doi: 10.1046/j.1365-2141.2003.04210.x. Br J Haematol. 2003. PMID: 12648071 Free article.

3

P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.

Turzanski J, Grundy M, Shang S, Russell N, Pallis M. Turzanski J, et al. Among authors: pallis m. Exp Hematol. 2005 Jan;33(1):62-72. doi: 10.1016/j.exphem.2004.10.005. Exp Hematol. 2005. PMID: 15661399 Free article.

4

P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.

Grundy M, Seedhouse C, Russell NH, Pallis M. Grundy M, et al. Among authors: pallis m. BMC Cancer. 2011 Jun 16;11:254. doi: 10.1186/1471-2407-11-254. BMC Cancer. 2011. PMID: 21679421 Free PMC article.

5

Distinct poor prognostic subgroups of acute myeloid leukaemia, FLT3-ITD and P-glycoprotein-positive, have contrasting levels of FOXO1.

Seedhouse CH, Mills KI, Ahluwalia S, Grundy M, Shang S, Burnett AK, Russell NH, Pallis M. Seedhouse CH, et al. Among authors: pallis m. Leuk Res. 2014 Jan;38(1):131-7. doi: 10.1016/j.leukres.2013.10.030. Epub 2013 Nov 8. Leuk Res. 2014. PMID: 24268349

6

Quantitative assessment of the sensitivity of dormant AML cells to the BAD mimetics ABT-199 and ABT-737.

Yu N, Seedhouse C, Russell N, Pallis M. Yu N, et al. Among authors: pallis m. Leuk Lymphoma. 2018 Oct;59(10):2447-2453. doi: 10.1080/10428194.2018.1434884. Epub 2018 Feb 12. Leuk Lymphoma. 2018. PMID: 29431553

7

P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.

Pallis M, Russell N. Pallis M, et al. Blood. 2000 May 1;95(9):2897-904. Blood. 2000. PMID: 10779437 Free article.

8

Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia.

Higashi Y, Turzanski J, Pallis M, Russell NH. Higashi Y, et al. Among authors: pallis m. Br J Haematol. 2000 Nov;111(2):565-9. doi: 10.1046/j.1365-2141.2000.02354.x. Br J Haematol. 2000. PMID: 11122104 Free article.

9

Interleukin-1beta maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways.

Turzanski J, Grundy M, Russell NH, Pallis M. Turzanski J, et al. Among authors: pallis m. Leukemia. 2004 Oct;18(10):1662-70. doi: 10.1038/sj.leu.2403457. Leukemia. 2004. PMID: 15306822

10

Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia.

Pallis M, Russell N. Pallis M, et al. Leukemia. 2004 Dec;18(12):1927-30. doi: 10.1038/sj.leu.2403511. Leukemia. 2004. PMID: 15483678 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters